Natrogen Therapeutics International, Inc. — Form D
Natrogen Therapeutics International, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-02. The offering totals $1.9M, of which $1.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-04-02
- Form: D
- Accession: 0001344213-10-000005
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.9M
- Amount sold: $1.4M
- Remaining: $467K
- Investors: 6
- Date of first sale: 2007-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-83126
Issuer
- Name: Natrogen Therapeutics International, Inc.
- CIK: 0001344213
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 315 East 68th St., New York, NY, 10065
- Phone: 212-988-7490
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| James P McCarron Jr. | Director | New York, NY |
| Basil P Hanss | Director | New York, NY |
| Allen Tsao | Director | Windlake, WI |
| Simon Mencher | Director | New York, NY |
| Simon Mencher | Executive Officer | New York, NY |
| Xiaomei P Liu | Executive Officer | New York, NY |
| Longgui Wang | Director | Flusing, NY |
| Longgui Wang | Executive Officer | Flusing, NY |
| Richard P Bartlett | Director | New York, NY |
Other filings by this issuer (2)
More